| BHYSX | FHBRX | BHYSX / FHBRX | |
| Total Expense Ratio | 0.91 | 0.64 | 142% |
| Annual Report Gross Expense Ratio | 0.93 | 0.71 | 131% |
| Fund Existence | 28 years | 10 years | - |
| Gain YTD | 2.026 | 1.927 | 105% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 27.7B | 489M | 5,665% |
| Annual Yield % from dividends | 6.42 | 5.87 | 109% |
| Returns for 1 year | 5.24 | 4.26 | 123% |
| Returns for 3 years | 28.56 | 25.58 | 112% |
| Returns for 5 years | 23.12 | 18.54 | 125% |
| Returns for 10 years | 65.36 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 42.26 | 0.60 | +1.44% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| XITK | 201.81 | 1.21 | +0.61% |
| State Street® SPDR® FctSt Innvtv TechETF | |||
| DTRE | 42.85 | N/A | N/A |
| First Trust Alerian Dsrupt Tech RE ETF | |||
| LMNX | 18.59 | N/A | N/A |
| Defiance Daily Target 2X Long LMND ETF | |||
| ELCV | 31.82 | -0.04 | -0.12% |
| Eventide High Dividend ETF | |||